Download Citation
Article Source:
A Phase I Dose Escalation Study of the Triple Angiokinase Inhibitor Nintedanib Combined with Low-Dose Cytarabine in Elderly Patients with Acute Myeloid Leukemia
Schliemann C,
Gerss J,
Wiebe S,
Mikesch JH,
Knoblauch N,
et al.
(2016)
A Phase I Dose Escalation Study of the Triple Angiokinase Inhibitor Nintedanib Combined with Low-Dose Cytarabine in Elderly Patients with Acute Myeloid Leukemia.
PLOS ONE 11(10): e0164499.
https://doi.org/10.1371/journal.pone.0164499